US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eisai Co., Ltd.

7.44

-0.0500-0.67%

Volume:51.83K

Turnover:385.22K

Market Cap:8.46B

PE:42.04

High:7.47

Open:7.30

Low:7.30

Close:7.49

52wk High:9.22

52wk Low:5.94

Shares:1.14B

Float Shares:1.08B

Volume Ratio:0.97

T/O Rate:0.00%

Dividend:0.27

Dividend Rate:3.59%

EPS(TTM):0.1770

EPS(LYR):0.2444

ROE:5.90%

ROA:2.43%

PB:1.55

PE(LYR):30.44

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

This Medicare premium just crossed $200 for the first time. Here's why.

Eisai, Biogen announces Health Canada granted authorization for ‘LEQEMBI’

Merck, Eisai announce follow-up data on KEYTRUDA plus LENVIMA

Eisai, Biogen announce U.S. availability of LEQEMBI IQLIK

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ESAIY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESAIY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":7.44,"timestamp":1765227600000,"preClose":7.49,"halted":0,"volume":51828,"delay":15,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"12-08 16:00:00 EST Delay","open":7.3,"high":7.47,"low":7.3,"amount":385222.6134000001,"amplitude":0.022697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765290600000},"marketStatusCode":1,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":7.44,"volumeRatio":0.9731678483075799},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","floatShares":1076747898,"roa":"2.43%","roe":"5.90%","lyrEps":0.244385,"volumeRatio":0.9731678483075799,"shares":1137465824,"dividePrice":0.267,"high":7.47,"amplitude":0.022697,"preClose":7.49,"low":7.3,"week52Low":5.94,"pbRate":"1.55","psRate":"1.64","week52High":9.22,"institutionHeld":0,"latestPrice":7.44,"eps":0.176978,"divideRate":0.035887,"volume":51828,"delay":15,"ttmEps":0.176978,"open":7.3,"prevYearClose":6.74,"prevWeekClose":7.49,"prevMonthClose":7.864,"prevQuarterClose":8.51,"fiveDayClose":7.68,"twentyDayClose":7,"sixtyDayClose":8.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESAIY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":null},{"date":"2024-08-01","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722542400000,"name":null,"time":"Post Market","dateTimestamp":1722484800000,"actualEps":null},{"date":"2024-05-14","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715716800000,"name":null,"time":"Post Market","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESAIY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESAIY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.1429,"hold":0.6429,"sell":0.0714,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6429,"analysts":14,"updateTime":1764910800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESAIY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2585172253","title":"This Medicare premium just crossed $200 for the first time. Here's why.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585172253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585172253?lang=en_us&edition=fundamental","pubTime":"2025-11-22 21:30","pubTimestamp":1763818200,"startTime":"0","endTime":"0","summary":"The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in Medicare Advantage and outpatient care next year. Medicare Part B premiums are going up by 9.7% in 2026.Blame medical inflation and more people in need of costly care for the 9.7% jump in Medicare Part B premiums next year.Starting in January, people on Medicare will pay $202.90 in 2026 for their monthly Part B premiums, which provide coverage for services like doctor's visits, outpatient procedures and medications administered by a healthcare professional. That's up from $185.00 in 2025.The government has a simple explanation for the largest-ever dollar increase for these premiums, citing \"projected growth in overall healthcare spending.\" Medicare's spending growth is supposed to increase 8.9% across 2026 and 2027, outpacing the 5.6% jump in predicted health spending growth in general.Plus, more care is moving from inpatient settings to less expensive outpatient ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","ESAIY","LU2461242641.AUD","LU1069347547.HKD","SG9999002224.SGD","LU1571399168.USD","IE00BBT3K403.USD","LU0553294199.USD","BK4139","LU1430594728.SGD","CMS","LU1093756325.SGD","LU0965508806.USD","BK4585","IE00BLSP4239.USD","LU2362540622.SGD","LU1934455863.HKD","REGN","LU0122379950.USD","LU2106854487.HKD","IE00B1BXHZ80.USD","BIIB","LU1035773651.USD","IE00BLSP4452.SGD","LU2468319806.SGD","MRK","SG9999001176.SGD","LU2362541273.HKD","LU0265550946.USD","LU0320765646.SGD","LU0070302665.USD","LU0823416689.USD","LU0985320562.USD","LU0965509101.SGD","LU1917777945.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BSNM7G36.USD","BK4588","IE00B2B36J28.USD","BK4550","BK4516","LU1941712348.USD","LU2346227817.USD","LU0208291251.USD","BK4559","LU1066051498.USD","LU0106261372.USD","SG9999002232.USD","LU2361045086.USD"],"gpt_icon":0},{"id":"2578666765","title":"Eisai, Biogen announces Health Canada granted authorization for ‘LEQEMBI’","url":"https://stock-news.laohu8.com/highlight/detail?id=2578666765","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578666765?lang=en_us&edition=fundamental","pubTime":"2025-10-27 08:20","pubTimestamp":1761524408,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that Health Canada has issued a Notice of Compliance with Conditions for humanized anti-soluble aggregate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-health-canada-granted-authorization-for-leqembi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-health-canada-granted-authorization-for-leqembi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9P08.USD","BK4139","IE00B894F039.SGD","ESAIY","LU0234570918.USD","BK4588","LU0889565916.HKD","BK4532","BK4585","BK4007","BIIB","LU0109394709.USD","BK4533","LU0320765992.SGD","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2576071115","title":"Merck, Eisai announce follow-up data on KEYTRUDA plus LENVIMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2576071115","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576071115?lang=en_us&edition=fundamental","pubTime":"2025-10-19 22:35","pubTimestamp":1760884506,"startTime":"0","endTime":"0","summary":"Merck (MRK) and Eisai (ESAIY) announced long-term follow-up data continued to show durable benefit of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LEN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-eisai-announce-follow-up-data-on-keytruda-plus-lenvima-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-eisai-announce-follow-up-data-on-keytruda-plus-lenvima-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BK4516","LU1989771016.USD","LU0238689110.USD","LU0203345920.USD","LU0265550946.USD","LU1989772923.USD","LU2361045086.USD","SG9999002224.SGD","LU1066051811.HKD","LU1974910355.USD","SGXZ57979304.SGD","LU0320765646.SGD","LU1093756168.USD","LU0320765489.SGD","IE00BLSP4239.USD","ESAIY","IE00BLSP4452.SGD","BK4550","LU1116320901.HKD","LU0289739699.SGD","IE000M9KFDE8.USD","LU2461242641.AUD","IE00BBT3K403.USD","LU2089984988.USD","LU0234572021.USD","LU1941712264.USD","SG9999013999.USD","LU0106261372.USD","LU0208291251.USD","SG9999015358.SGD","SG9999001440.SGD","LU2106854487.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1430594728.SGD","BK4588","SG9999001176.SGD","BK4585","IE00B4R5TH58.HKD","LU1934455194.USD","LU1941712348.USD","SG9999014542.SGD","BK4534","LU1035773651.USD","MRK","LU1989772840.SGD","LU1066051225.USD","LU1934455277.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2573983098","title":"Eisai, Biogen announce U.S. availability of LEQEMBI IQLIK","url":"https://stock-news.laohu8.com/highlight/detail?id=2573983098","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573983098?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:35","pubTimestamp":1759782939,"startTime":"0","endTime":"0","summary":"Eisai Co. (ESAIY) and Biogen (BIIB) announced that lecanemab-irmb subcutaneous injection, U.S. brand name: LEQEMBI IQLIKTM, is now available in the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-u-s-availability-of-leqembi-iqlik-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announce-u-s-availability-of-leqembi-iqlik-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","IE00B894F039.SGD","BIIB","IE00B19Z9Z06.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","BK4588","BK4532","LU0109394709.USD","BK4585","BK4533","BK4007","IE00B19Z9P08.USD","ESAIY"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ESAIY\",params:#limit:6,delay:false,,,undefined,":[]}}